Anti-Diabetic Potential of the American Mistletoe Phoradendron brachystachyum: In Vitro and In Silico Approach
Authors:
- Luis Aurelio Montoya-InzunzaLMLuis Aurelio Montoya-Inzunza
- Lennin Isaac Garrido-PalazuelosLGLennin Isaac Garrido-Palazuelos
- José Roberto Aguirre-SánchezJAJosé Roberto Aguirre-Sánchez
- Erika Ortega-HernándezEOErika Ortega-Hernández
- J. Basilio HerediaJ. Basilio Heredia
- Jose Reyes Gonzalez-GalavizJose Reyes Gonzalez-Galaviz
- Pedro de Jesús Bastidas-BastidasPBPedro de Jesús Bastidas-Bastidas
- José Andrés Medrano-FélixJMJosé Andrés Medrano-Félix
- Luis Angel Cabanillas-BojórquezLuis Angel Cabanillas-Bojórquez
- Marilena Antunes-RicardoMarilena Antunes-Ricardo
- Erick Paul Gutiérrez-GrijalvaErick Paul Gutiérrez-Grijalva
Preprint
- 27 March 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The anti-diabetic potential of Phoradendron brachystachyum was evaluated through the assessment of the cellular antioxidant, anti-inflammatory, and glucose uptake-modulating activities of its non-digested (ND) and digested (D) extracts from leaves (L), stems (S), and whole aerial parts (WAP). The WAP non-digested extract exhibited the highest cellular antioxidant activity, with a 99% inhibition of reactive oxygen species in Caco-2 cells, and a significant reduction in nitric oxide production in RAW 264.7 cells. Crucially, in an insulin-resistant HepG2 cell model, the WAP extract significantly increased glucose consumption to 82.67%, retaining high bioactivity (66.55%) even after the digestion process. UPLC-MS analysis identified quercetin-3-O-rhamnoside as the most abundant in all extracts. Complementary the in silico molecular docking and 100 ns molecular dy-namics simulations identified spiraeoside and quercetin-3-O-alpha-L-rhamnopyranoside as potent α-glucosidase inhibitors (-9.9kcal mol-1), while sakuranetin and spiraeoside showed higher affinity for α-amylase (-9.0 kcal mol-1). These in vitro and in silico findings provide a scientific basis for the ethnopharmacological use P. brachystachyum, showing its potential to modulate glucose metabolism.Keywords
All Related Versions
This publication has 64 references indexed in Scilit:
- Anti-diabetic drugs recent approaches and advancementsBioorganic & Medicinal Chemistry, 2020
- Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivativesBioorganic Chemistry, 2018
- Dimeric procyanidins are inhibitors of NF-κB–DNA bindingBiochemical Pharmacology, 2009
- Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidaseArchives of Biochemistry and Biophysics, 2008
- Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airwaysBiochemical Pharmacology, 2007
- NF-κB activation by reactive oxygen species: Fifteen years laterBiochemical Pharmacology, 2006
- The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-κB regulation, in RAW264.7 cellsArchives of Biochemistry and Biophysics, 2006
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Medicinal Plants: Historical and Cross-Cultural Usage PatternsAnnals of Epidemiology, 2005
- Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivityArchives of Biochemistry and Biophysics, 2004